GW PHARMACEUTICALS PLC Proceeds from Common Stock Issued
GW PHARMACEUTICALS PLC reported Proceeds from Common Stock Issued of $324.64 million for the 3-month period ending 2018-12-31, per its 10-K filed 2021-02-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2021-02-26
- GW PHARMACEUTICALS PLC proceeds from issuance of common stock for the quarter ending 2018-12-31 was $324.64M, a 8.96% increase year-over-year.
- GW PHARMACEUTICALS PLC proceeds from issuance of common stock for the quarter ending 2017-12-31 was $297.93M.
- GW PHARMACEUTICALS PLC proceeds from issuance of common stock for fiscal 2018 was $297.93M.
- GW PHARMACEUTICALS PLC proceeds from issuance of common stock for fiscal 2016 was $273.80M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|
| 2018-12-31 | $324.64M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $297.93M 10-K · filed 2021-02-26 | |
| 2017-12-31 | $297.93M 10-K · filed 2021-02-26 | |
| 2016-09-30 | $273.80M 10-KT · filed 2019-02-28 |